Tapewire

NYSE · USD

SHW

SHERWIN WILLIAMS CO

Export transactions ↓
Tapewire entity
2948
SEC CIK
0000089800
Parsed reports
715

Last 12 months

Inside the activity.

0 purchase rows · 4 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202602
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202602
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 24, 2016 Filed Oct 25, 2016 16:29 UTC
Mistysyn Allen JSVP - Finance
GrantEmployee Stock Option (Right to Buy) · Derivative 10,200 $0.00 Strike: $277.65 $0.00
Disclosure

SEC source: 0001209191-16-146823 · doc4.xml · derivative · entry 1

Mistysyn Allen J · CIK 0001489329 · SVP - Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,200

Underlying: Common Stock · 10,200 shares

Expires 2026-10-23

F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on October 24, 2017.

Read SEC document
October 18, 2016 Filed Oct 20, 2016 15:01 UTC
Wells Robert JSVP-Corp Comm & Public Affairs
GrantEmployee Stock Option (Right to Buy) · Derivative 4,500 $0.00 Strike: $270.12 $0.00
Disclosure

SEC source: 0001209191-16-146444 · doc4.xml · derivative · entry 3

Wells Robert J · CIK 0001353063 · SVP-Corp Comm & Public Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,500

Underlying: Common Stock · 4,500 shares

Expires 2026-10-17

F4 · derivative.exercise_date: The option vests in three equal annual installments beginning on October 18, 2017.

Read SEC document
October 18, 2016 Filed Oct 20, 2016 15:01 UTC
Wells Robert JSVP-Corp Comm & Public Affairs
GrantCommon Stock 1,686 $0.00 $0.00
Disclosure

SEC source: 0001209191-16-146444 · doc4.xml · nonDerivative · entry 1

Wells Robert J · CIK 0001353063 · SVP-Corp Comm & Public Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,805

F1 · kind: Grant of restricted stock units under the 2006 Equity and Performance Incentive Plan.

F2 · balance_after: Of shares listed, 1,750 are restricted stock and 2,736 are restricted stock units.

Read SEC document
October 18, 2016 Filed Oct 20, 2016 14:50 UTC
HENNESSY SEAN PSVP-Finance & CFO
GrantEmployee Stock Option (Right to Buy) · Derivative 14,100 $0.00 Strike: $270.12 $0.00
Disclosure

SEC source: 0001209191-16-146437 · doc4.xml · derivative · entry 1

HENNESSY SEAN P · CIK 0001203507 · SVP-Finance & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,100

Underlying: Common Stock · 14,100 shares

Expires 2026-10-17

F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on October 18, 2017.

Read SEC document
October 18, 2016 Filed Oct 20, 2016 14:57 UTC
Sewell David BPresident, Global Finishes Grp
GrantEmployee Stock Option (Right to Buy) · Derivative 7,200 $0.00 Strike: $270.12 $0.00
Disclosure

SEC source: 0001209191-16-146441 · doc4.xml · derivative · entry 1

Sewell David B · CIK 0001617514 · President, Global Finishes Grp

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,200

Underlying: Common Stock · 7,200 shares

Expires 2026-10-17

F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on October 18, 2017.

Read SEC document
October 18, 2016 Filed Oct 20, 2016 14:59 UTC
GILLIGAN THOMAS PSVP-Human Resources
GrantEmployee Stock Option (Right to Buy) · Derivative 6,600 $0.00 Strike: $270.12 $0.00
Disclosure

SEC source: 0001209191-16-146443 · doc4.xml · derivative · entry 1

GILLIGAN THOMAS P · CIK 0001661198 · SVP-Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,600

Underlying: Common Stock · 6,600 shares

Expires 2026-10-17

F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on October 18, 2017.

Read SEC document
October 18, 2016 Filed Oct 20, 2016 14:55 UTC
Baxter Joel D.Pres. & GM, Glob. Supply Chain
GrantEmployee Stock Option (Right to Buy) · Derivative 7,200 $0.00 Strike: $270.12 $0.00
Disclosure

SEC source: 0001209191-16-146440 · doc4.xml · derivative · entry 1

Baxter Joel D. · CIK 0001666161 · Pres. & GM, Glob. Supply Chain

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,200

Underlying: Common Stock · 7,200 shares

Expires 2026-10-17

F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on October 18, 2017.

Read SEC document
October 18, 2016 Filed Oct 20, 2016 14:54 UTC
KILBANE CATHERINE MSVP, Gen. Counsel & Secretary
GrantEmployee Stock Option (Right to Buy) · Derivative 7,700 $0.00 Strike: $270.12 $0.00
Disclosure

SEC source: 0001209191-16-146439 · doc4.xml · derivative · entry 1

KILBANE CATHERINE M · CIK 0001266110 · SVP, Gen. Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,700

Underlying: Common Stock · 7,700 shares

Expires 2026-10-17

F1 · derivative.exercise_date: The option vests in three annual installments of 2,567, 2,567 and 2,566 beginning on October 18, 2017.

Read SEC document
October 18, 2016 Filed Oct 20, 2016 14:52 UTC
Davisson Robert JPresident, The Americas Group
GrantEmployee Stock Option (Right to Buy) · Derivative 11,200 $0.00 Strike: $270.12 $0.00
Disclosure

SEC source: 0001209191-16-146438 · doc4.xml · derivative · entry 1

Davisson Robert J · CIK 0001504881 · President, The Americas Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,200

Underlying: Common Stock · 11,200 shares

Expires 2026-10-17

F1 · derivative.exercise_date: The option vests in three annual installments of 3,734, 3,733 and 3,733 beginning on October 18, 2017.

Read SEC document
October 18, 2016 Filed Oct 20, 2016 14:48 UTC
Connor Christopher MDirector · Executive Chairman
GrantEmployee Stock Option (Right to Buy) · Derivative 24,700 $0.00 Strike: $270.12 $0.00
Disclosure

SEC source: 0001209191-16-146436 · doc4.xml · derivative · entry 1

Connor Christopher M · CIK 0001181680 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,700

Underlying: Common Stock · 24,700 shares

Expires 2026-10-17

F1 · derivative.exercise_date: The option vests in three annual installments of 8,234, 8,233 and 8,233 beginning on October 18, 2017.

Read SEC document
October 18, 2016 Filed Oct 20, 2016 14:46 UTC
MORIKIS JOHN GDirector · President & CEO
GrantEmployee Stock Option (Right to Buy) · Derivative 52,900 $0.00 Strike: $270.12 $0.00
Disclosure

SEC source: 0001209191-16-146435 · doc4.xml · derivative · entry 1

MORIKIS JOHN G · CIK 0001203523 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,900

Underlying: Common Stock · 52,900 shares

Expires 2026-10-17

F1 · derivative.exercise_date: The option vests in three annual installments of 17,634, 17,633 and 17,633 beginning on October 18, 2017.

Read SEC document
October 07, 2016 Filed Oct 11, 2016 12:42 UTC GrantCommon Stock 103 $266.36 $27,435.08
Disclosure

SEC source: 0001209191-16-145507 · doc4.xml · nonDerivative · entry 1

KRAMER RICHARD J · CIK 0001201067 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Deferred Plan

Disclosed balance after: 1,896

F1 · kind: Shares were acquired in an exempt transaction in connection with the Director Deferred Fee Plan; reporting person has the right to direct the vote for such shares.

F2 · balance_after: Shares listed are held pursuant to the Director Deferred Fee Plan, which includes shares acquired pursuant to the dividend reinvestment feature of such plan.

Read SEC document
October 07, 2016 Filed Oct 11, 2016 12:38 UTC GrantCommon Stock 29 $266.36 $7,724.44
Disclosure

SEC source: 0001209191-16-145506 · doc4.xml · nonDerivative · entry 1

POON CHRISTINE A · CIK 0001189014 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Deferred Plan

Disclosed balance after: 320

F1 · kind: Shares were acquired in an exempt transaction in connection with the Director Deferred Fee Plan; reporting person has the right to direct the vote for such shares.

F2 · balance_after: Shares listed are held pursuant to the Director Deferred Fee Plan, which includes shares acquired pursuant to the dividend reinvestment feature of such plan.

Read SEC document
October 07, 2016 Filed Oct 11, 2016 12:35 UTC GrantPhantom Stock · Derivative 102.33 $268.74 $27,500.16
Disclosure

SEC source: 0001209191-16-145505 · doc4.xml · derivative · entry 1

KROPF SUSAN J · CIK 0001051402 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,386.44

Underlying: Common Stock · 102.33 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents the number of shares of phantom stock acquired by the reporting person (in an exempt transaction) under the Director Deferred Fee Plan. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in cash generally upon the reporting person's retirement.

F1 · shares: Represents the number of shares of phantom stock acquired by the reporting person (in an exempt transaction) under the Director Deferred Fee Plan. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in cash generally upon the reporting person's retirement.

F1 · derivative.exercise_date: Represents the number of shares of phantom stock acquired by the reporting person (in an exempt transaction) under the Director Deferred Fee Plan. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in cash generally upon the reporting person's retirement.

F1 · derivative.expiration_date: Represents the number of shares of phantom stock acquired by the reporting person (in an exempt transaction) under the Director Deferred Fee Plan. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in cash generally upon the reporting person's retirement.

F2 · balance_after: Includes phantom stock acquired pursuant to the dividend reinvestment feature of the plan.

Read SEC document
October 07, 2016 Filed Oct 11, 2016 12:30 UTC GrantCommon Stock 103 $266.36 $27,435.08
Disclosure

SEC source: 0001209191-16-145504 · doc4.xml · nonDerivative · entry 1

WUNNING STEVEN H · CIK 0001171788 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Deferred Plan

Disclosed balance after: 633

F1 · kind: Shares were acquired in an exempt transaction in connection with the Director Deferred Fee Plan; reporting person has the right to direct the vote for such shares.

F2 · balance_after: Shares listed are held pursuant to the Director Deferred Fee Plan, which includes shares acquired pursuant to the dividend reinvestment feature of such plan.

Read SEC document
October 07, 2016 Filed Oct 11, 2016 12:27 UTC GrantPhantom Stock · Derivative 60.93 $268.74 $16,374.33
Disclosure

SEC source: 0001209191-16-145503 · doc4.xml · derivative · entry 4

Kadien Thomas G · CIK 0001327759 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,557.66

Underlying: Common Stock · 60.93 shares

Expires not disclosed

F4 · derivative.exercise_price: Represents the number of shares of phantom stock acquired by the reporting person (in an exempt transaction) under the Director Deferred Fee Plan. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in cash generally upon the reporting person's retirement.

F4 · shares: Represents the number of shares of phantom stock acquired by the reporting person (in an exempt transaction) under the Director Deferred Fee Plan. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in cash generally upon the reporting person's retirement.

F4 · derivative.exercise_date: Represents the number of shares of phantom stock acquired by the reporting person (in an exempt transaction) under the Director Deferred Fee Plan. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in cash generally upon the reporting person's retirement.

F4 · derivative.expiration_date: Represents the number of shares of phantom stock acquired by the reporting person (in an exempt transaction) under the Director Deferred Fee Plan. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in cash generally upon the reporting person's retirement.

F5 · balance_after: Includes phantom stock acquired pursuant to the dividend reinvestment feature of the plan.

Read SEC document
October 07, 2016 Filed Oct 11, 2016 12:27 UTC GrantCommon Stock 61 $266.36 $16,247.96
Disclosure

SEC source: 0001209191-16-145503 · doc4.xml · nonDerivative · entry 1

Kadien Thomas G · CIK 0001327759 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Deferred Plan

Disclosed balance after: 2,573

F1 · kind: Shares were acquired in an exempt transaction in connection with the Director Deferred Fee Plan; reporting person has the right to direct the vote for such shares.

F2 · balance_after: Shares listed are held pursuant to the Director Deferred Fee Plan, which includes shares acquired pursuant to the dividend reinvestment feature of such plan.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.